Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH

FEBS Journal

Volumn 275, Issue 3, 2008, Pages 449-457

  Selvatici, Rita ^a,c   Falzarano, Sofia ^a   Franceschetti, Lara ^a   Mollica, Adriano ^b   Guerrini, Remo ^a   Siniscalchi, Anna ^a   Spisani, Susanna ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Section of Medical Genetics Department of Experimental and Diagnostic Medicine   (Italy)

Author keywords

Chemotaxis; Human neutrophils; Lysozyme; PKC; PKI55

Indexed keywords

ESTER DERIVATIVE; HYDROXIDE; LYSOZYME; METHIONYLLEUCYLPHENYLALANYLHYDROXIDE; PROTEIN KINASE C; PROTEIN PKI55; SUPEROXIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; BRAIN; CELL SURVIVAL; ENZYME ACTIVATION; HUMANS; HYDROPHOBICITY; ISOENZYMES; MOLECULAR SEQUENCE DATA; MURAMIDASE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PEPTIDES; PROTEIN KINASE C; PROTEINS; RATS; SUPEROXIDES;

RATTUS;

EID: 38149009032     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.06212.x     Document Type: Article

References (36)

1. Selvatici R, Falzarano S, Mollica A Spisani S (2006) Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur J Pharmacol 534, 1 11.
2. Boulay F, Tardif M, Brouchon L Vignais P (1990) Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem Biophys Res Commun 168, 1103 1109.
3. Bao L, Gerard NP, Eddy RL Jr., Shows TB Gerard C (1992) Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics 13, 437 440.
4. Le Y, Oppenheim JJ Wang JM (2001) Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev 12, 91 105.
5. Spisani S Selvatici R (2006) FMLP-OMe analogues trigger specific signalling pathways in the physiological functions of human neutrophils. In Trends in Cellular Signaling (Caplin DE ed pp 1 40. Nova Science Publishers, Inc., New York, NY.
6. Spisani S, Falzarano S, Traniello S, Nalli M Selvatici R (2005) A 'pure' chemoattractant formylpeptide analogue triggers a specific signalling pathway in human neutrophil chemotaxis. FEBS J 272, 883 891.
7. Battaini F Mochly-Rosen D (2007) Happy birthday protein kinase C: past, present and future of a superfamily. Pharmacol Res 55, 461 466.
8. Brandman R, Disatnik MH, Churchill E Mochly-Rosen D (2007) Peptides derived from the C2 domain of protein kinase C epsilon (epsilon PKC) modulate epsilon PKC activity and identify potential protein-protein interaction surfaces. J Biol Chem 282, 4113 4123.
9. Budas GR, Koyanagi T, Churchill EN Mochly-Rosen D (2007) Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic. Biochem Soc Trans 35, 1021 1026.
10. Basu A (1993) The potential of protein kinase C as a target for anticancer treatment. Pharmacol Ther 59, 257 280.
11. Frank RN (2002) Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors. Am J Ophthalmol 133, 693 698.
12. Selvatici R, Melloni E, Ferrati M, Piubello C, Marincola FC Gandini E (2003) Adaptative value of a PKC-PKI55 feedback loop of inhibition that prevents the kinase's deregulation. J Mol Evol 57, 131 139.
13. Selvatici R, Falzarano S, Franceschetti L, Spisani S Siniscalchi A (2007) Effects of PKI55 protein, an endogenous protein kinase C modulator, on specific PKC isoforms activity and on human T cells proliferation. Arch Biochem Biophys 462, 74 82.
14. Selvatici R, Falzarano S, Traniello S, Pagani Zecchini G Spisani S (2003) Formylpeptides trigger selective molecular pathways that are required in the physiological functions of human neutrophils. Cell Signal 15, 77 83.
15. Manning G, Whyte DB, Martinez R, Hunter T Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298, 1912 1934.
16. Yamatsugu K, Motoki R, Kanai M Shibasaki M (2006) Identification of potent, selective protein kinase C inhibitors based on a phorbol skeleton. Chem Asian J 1, 314 321.
17. Swannie HC Kaye SB (2002) Protein kinase C inhibitors. Curr Oncol Rep 4, 37 46.
18. Kheifetsa V Mochly-Rosen D (2007) Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function. Pharmacol Res 55, 467 476.
19. Mochly-Rosen D Kauvar LM (1998) Modulating protein kinase C signal transduction. Adv Pharmacol 44, 91 145.
20. Way KJ, Chou E King GL (2000) Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol Sci 21, 181 187.
21. Haverstick DM, Sakai H Gray LS (1992) Lymphocyte adhesion can be regulated by cytoskeleton-associated, PMA-induced capping of surface receptors. Am J Physiol 262, C916 C926.
22. Nishikawa M, Sellers JR, Adelstein RS Hidaka H (1984) Protein kinase C modulates in vitro phosphorylation of the smooth muscle heavy meromyosin by myosin light chain kinase. J Biol Chem 259, 8808 8814.
23. Parsey MV Lewis GK (1993) Actin polymerization and pseudopod reorganization accompany anti-CD3-induced growth arrest in Jurkat T cells. J Immunol 151, 1881 1893.
24. Juliano RL (2002) Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. Annu Rev Pharmacol Toxicol 42, 283 323.
25. Katanev VL (2001) Signal transduction in neutrophil chemotaxis. Biochemistry (Moscow) 66, 351 368.
26. Niggli V, Djafarzadeh S Keller H (1999) Stimulus-induced selective association of actin-associated proteins (alpha-actinin) and protein kinase C isoforms with the cytoskeleton of human neutrophils. Exp Cell Res 250, 558 568.
27. Frow EK, Reckless J Grainger DJ (2004) Tools for anti-inflammatory drug design: in vitro models of leukocyte migration. Med Res Rev 24, 276 298.
28. Goekjian PG Jirousek MR (1999) Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors, and agents in development. Curr Med Chem 6, 877 903.
29. Benoiton NL (2005) Solid-phase synthesis. In Chemistry of peptide synthesis (Benoiton NL, ed pp. 125 154. Taylor & Francis, London.
30. Carpino LA (1993) 1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive. J Am Chem Soc 115, 4397 4398.
31. Sole' NA Barany G (1992) Optimization of solid-phase synthesis of [Ala8]-dynorphin A. J Org Chem 57, 5399 5403.
32. Orr JW Newton AC (1992) Interaction of protein kinase C with phosphatidylserine. 1. Cooperativity in lipid binding. Biochemistry 31, 4661 4667.
33. Edwards AS, Faux MC, Scott JD Newton AC (1999) Carboxyl-terminal phosphorylation regulates the function and subcellular localization of protein kinase C betaII. J Biol Chem 274, 6461 6468.
34. Zigmond SH Hirsch JG (1973) Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med 137, 387 410.
35. Cavicchioni G, Turchetti M, Varani K, Falzarano S Spisani S (2003) Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide. Bioorg Chem 31, 322 330.
36. Brown R, Jarvis K Hyland K (1989) Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal Biochem 180, 136 139.